SelectQuote (SLQT) Q1 2027 Earnings Call Transcript

SelectQuote (SLQT) reported Q1 2027 revenue of $280M, down 15% YoY, with an adjusted EBITDA loss of $17M. Senior revenue fell 14% YoY, while Medicare Advantage policies decreased 18%. Healthcare Services revenue dropped 16%, but EBITDA grew 56%. The company maintained full-year guidance and plans a reverse stock split. Management prioritized profitability over volume, leveraging AI and operational efficiencies.

Original reporting
Published Nov 4, 2026, 7:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 7:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SelectQuote (SLQT) Q1 2027 Earnings Call Transcript — source image
Decision brief

The 30-second read

$SLQTBearishMed
01

Why it matters

Management reiterated FY2027 guidance while emphasizing operational efficiency (AI call screening, pharmacy management system) and cash-flow ramp expectations; however, reported Senior and Healthcare Services revenue declines reflect ongoing policy and pricing headwinds.

02

Market read

Traders can update models for FY2027 revenue, adjusted EBITDA, and operating cash flow based on reiterated guidance and segment-level KPI shifts tied to IRA and AEP dynamics.

03

What to watch

Reverse stock split mechanics and the Nov. 10 shareholder meeting could affect near-term liquidity and sentiment, while the IRA impact may evolve as CMS commission rates and carrier plan features change during AEP.

Relevance 8/10Novelty 7/10Timing: post-earnings call, guidance and reverse-split shareholder meeting (Nov. 10) in focus

Background

SelectQuote’s fiscal Q1 2027 call focused on Medicare Advantage enrollment season (AEP), Senior agent force reduction, and SelectRx pharmacy services performance amid Inflation Reduction Act drug pricing effects.

Company-level read

Ticker impact

$SLQTBearishMedium confidence
Context

SelectQuote reported Q1 results and reiterated FY2027 revenue ($1.35B-$1.45B) and adjusted EBITDA ($90M-$115M) guidance while discussing IRA headwinds and a reverse split plan.

Expected impact

Likely mixed reaction, with upside from reiterated FY2027 targets and margin/cash-flow improvements offset by revenue headwinds from the Inflation Reduction Act and shrinking Medicare Advantage policy counts.

Evidence & confidence

The article contains fresh, company-specific quarterly metrics and explicit FY2027 guidance ranges, plus management commentary on IRA-driven revenue pressure and operational efficiency initiatives.

Market effects

Highlights Medicare Advantage enrollment-season disruption and AI-driven agent productivity as a competitive operating lever for Medicare-focused service providers.

None material indicated beyond US Medicare Advantage dynamics.

Limited, company-specific US healthcare services and Medicare Advantage enrollment season.

Counterpoint

The revenue decline and policy count drop may signal demand softness or competitive share loss, and margin improvement could be partly timing-driven rather than durable.

Key entities

  • SelectQuote, Inc.

    Reported Q1 2027 results, segment KPIs, and reiterated FY2027 guidance; discussed IRA headwinds and a reverse stock split plan.

  • Tim Danker

    CEO who attributed top-line pressure to the Inflation Reduction Act and discussed AEP disruption and agent-force sizing.

  • Ryan Clement

    CFO who discussed capital adequacy and reiterated FY2027 guidance ranges.

Related articles

$SLQTMed

SelectQuote Inc (SLQT) (Q1 2027) Earnings Call Highlights: Beats EBITDA and Cash Flow

SelectQuote Inc (SLQT) reported Q1 2027 earnings, beating EBITDA and cash flow estimates. President Bob noted stable plan termination and high beneficiary engagement. CFO Ryan Clement highlighted progress toward a $60M operating cash flow target, with potential future cash dividends. CEO Tim Danker mentioned strong front-end production and improved recapture rates. The company is expanding its Olathe facility and investing in technology for other sites.

$SLQTMedAI 8/10

SelectQuote places fewer Medicare policies but earns more on each one

SelectQuote (SLQT) approved 18% fewer Medicare Advantage policies in Q1 2027, with revenue falling to $280M from $329M. However, commission values per policy rose 16% to $890. The company is shrinking its agent force to improve efficiency, and adjusted EBITDA losses narrowed. Healthcare Services revenue fell 16% but adjusted EBITDA rose 56%. SelectQuote maintained its full-year guidance and faces a False Claims Act lawsuit.

$SLQTMed

What SelectQuote (SLQT) Said on Its Q1 Earnings Call

SelectQuote (SLQT) reported Q1 earnings, with Senior revenue declining to $51M from $59M, but adjusted EBITDA loss narrowing. Healthcare Services revenue fell to $186M, while adjusted EBITDA rose 56% to $11M. Life Insurance revenue declined to $43M, but adjusted EBITDA increased 31% to $7M. The company plans a reverse stock split and invests in AI and technology. Management noted stability in commissions and potential carrier marketing efforts.

$SLQTMed

SelectQuote (SLQT) Q1 2027 Earnings Call Transcript

SelectQuote (SLQT) reported a Q1 2027 adjusted EBITDA loss of $17M, improved from last year. Revenue was $280M, down 15% YoY. Senior segment lost $12M (improved $9M YoY), while Healthcare Services EBITDA rose 56% YoY to $11M. The company reiterated its fiscal 2027 operating cash flow target of at least $60M, citing strong profitability and cash flow performance.

Med

SelectQuote, Inc. Q1 2027 Earnings Call Summary

SelectQuote reported a $15M year-over-year adjusted EBITDA gain in Q1 2027, driven by a focus on profitability over volume. Healthcare Services margins increased 60% through member base optimization. Revenue declines in the Senior segment were planned. Management expects $60M operating cash flow in fiscal 2027 and a path to cash-paying preferred dividends by fiscal 2028. The Inflation Reduction Act impacted revenue but was offset by reimbursements.